Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Non-Current Assets (2022 - 2025)

Treace Medical Concepts' Other Non-Current Assets history spans 4 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 200.0% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 200.0%, while the annual FY2025 figure was $1.2 million, 200.0% up from the prior year.
  • Other Non-Current Assets reached $1.2 million in Q4 2025 per TMCI's latest filing, up from $614000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.2 million in Q4 2025 to a low of $134000.0 in Q1 2022.
  • Average Other Non-Current Assets over 4 years is $329250.0, with a median of $146000.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: tumbled 32.09% in 2024, then surged 363.01% in 2025.
  • A 4-year view of Other Non-Current Assets shows it stood at $146000.0 in 2022, then changed by 0.0% to $146000.0 in 2023, then surged by 178.77% to $407000.0 in 2024, then skyrocketed by 200.0% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Other Non-Current Assets are $1.2 million (Q4 2025), $614000.0 (Q3 2025), and $676000.0 (Q2 2025).